Pralsetinib普拉替尼,2097132-94-8

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Pralsetinib

CAS No. : 2097132-94-8

MCE 国际站：Pralsetinib

产品活性：Pralsetinib (BLU-667) 是一种高效的选择性 RET 抑制剂。Pralsetinib (BLU-667) 抑制 WT RET，RET 突变体 V804L，V804M，M918T 和 CCDC6-RET 融合，IC₅₀ 分别为 0.4、0.3、0.4、0.4、0.4 nM。

研究领域：Protein Tyrosine Kinase/RTK

作用靶点：RET

In Vitro: Pralsetinib (BLU-667) demonstrates more than 10-fold increased potency over approved MKIs against oncogenic RET variants and resistance mutants.
?Pralsetinib (BLU-667) demonstrates potent activity (IC₅₀=0.4 nM) against common oncogenic RET alterations, including RET M918T, an activating mutation found in MTC, as well as the CCDC6-RET fusion observed in PTC and NSCLC.
?Pralsetinib (BLU-667) suppresses RET pathway signaling in a panel of RET-driven cell lines: LC2/ad (CCDC6-RET, NSCLC), MZ-CRC-1 (RET M918T, MTC), and TT (RET C634W, MTC).

In Vivo: Pralsetinib (BLU-667) potently inhibits growth of NSCLC and thyroid cancer xenografts driven by various RET mutations and fusions without inhibiting vascular endothelial growth factor receptor 2 (VEGFR-2).
?Pralsetinib (BLU-667) shows dose dependent activity against both KIF5B-RET Ba/F3 and KIF5B-RET V804L Ba/F3 allograft tumors with doses as low as 10 mg/kg twice-daily.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Kinase Inhibitor Library  |  Protein Tyrosine Kinase Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Drug Repurposing Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Lung Cancer Compound Library  |  Targeted Therapy Drug Library   |  Anti-Liver Cancer Compound Library   |  Rare Diseases Drug Library  |  FDA-Approved Anticancer Drug Library  |  Heterocyclic Compound Library  |  Withdrawn Drug Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Lenvatinib  |  Regorafenib  |  Selpercatinib  |  TG101209  |  AST 487  |  Amuvatinib  |  BT-13  |  AD80  |  BBT594  |  GSK3179106  |  WHI-P180  |  WF-47-JS03  |  Zeteletinib  |  SPP-86  |  Vepafestinib  |  RET V804M-IN-1  |  RPI-1  |  trans-Pralsetinib  |  Enbezotinib  |  NSC194598  |  Pz-1  |  BT44  |  Pyrazoloadenine  |  RET-IN-3  |  AD57

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds